NMR Stock Nomura Holdings (NMR, $7.08) Moving Average Convergence Divergence (MACD) Histogram turned positive on October 27, 2025

GET DAILY SIGNALS

Get AI intraday signals

NMR - Nomura Holdings

MACD signal

View

Odds of UP Trend

Price: $7.08

Daily change: +$0.16 (+2.31%)

Daily volume: 909.7K

Capitalization: $20.9B

Industry: Investment Banks/Brokers

This is a Bullish indicator signaling NMR's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 51 similar cases where NMR's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

NMR in +1.84% Uptrend, rising for three consecutive days on November 10, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where NMR advanced for three days, in of 280 cases, the price rose further within the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on November 21, 2025. You may want to consider a long position or call options on NMR as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 242 cases where NMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for NMR turned negative on November 18, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

NMR moved below its 50-day moving average on November 17, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NMR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NMR broke above its upper Bollinger Band on November 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.949) is normal, around the industry mean (3.600). P/E Ratio (9.293) is within average values for comparable stocks, (69.537). NMR's Projected Growth (PEG Ratio) (0.815) is slightly lower than the industry average of (1.704). Dividend Yield (0.033) settles around the average of (0.035) among similar stocks. P/S Ratio (1.955) is also within normal values, averaging (1561448.250).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.